Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? - Dalle, S.; Beylot-Barry, M.; Bagot, M.; Lipsker, D.; Machet, L.; Joly, P.; Dompmartin, A.; D'Incan, M.; Maubec, E.; Grange, F.; Dereure, O.; Prey, S.; et al. (British journal of dermatology (1951), 2010)
Keywords: Adult; Aged; Aged, 80 and over; Antineoplastic Agents - therapeutic use; Biological and medical sciences; blastic plasmacytoid dendritic cell neoplasm; Bone Marrow Transplantation; Child; Cohort Studies; cutaneous lymphoma; Dendritic Cells; Dermatology; Female; Hematologic and hematopoietic diseases; Humans; leukaemia; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis; lymphoma; Lymphoma - drug therapy; Lymphoma - mortality; Lymphoma - radiotherapy; Lymphoma - surgery; Male; Medical sciences; Middle Aged; multicentric; Prognosis; Retrospective Studies; retrospective study; Skin Neoplasms - drug therapy; Skin Neoplasms - mortality; Skin Neoplasms - radiotherapy; Skin Neoplasms - surgery; Survival Analysis; Dendritic cell; multicentric; Dermatology; Leukemia; Homograft; Malignant hemopathy; Lymphoma; Treatment; Lymphoproliferative syndrome; Graft; Tumor; leukaemia; Skin; blastic plasmacytoid dendritic cell neoplasm; retrospective study; Cancer; cutaneous lymphoma